WebBoard Of Directors; Scientific Advisory Board; Partnering; Pipeline. Overview; Upifitamab Rilsodotin; XMT-1660; Technology Platforms. About ADCs; DolaLock Tecknology; … Web6 sep. 2016 · CAMBRIDGE, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., a biotechnology company focused on discovering and developing a pipeline...
Nuvalent Appoints Anna Protopapas as Chair of Board of Directors
Web1 dag geleden · 2024: Retired from AGF Board of Directors and appointed Vice-Chairman Emeritus of AGF. During his over 60 years with the firm, he also served as Chairman of AGF Asset Management Asia Ltd. and AGF ... Web1 dag geleden · 13.04.2024 - MONTREAL, April 13, 2024 (GLOBE NEWSWIRE) - Vision Marine Technologies Inc. (NASDAQ: VMAR) (“Vision Marine” or the “Company”), a global leader and innovator within the ... tavalo at cadence reviews
MERSANA THERAPEUTICS, INC. : Change in Directors or Principal …
WebDavid Mott has served as Chair of our Board of Directors since July 2012. Mr. Mott is a private investor through Mott Family Capital. From September 2008 until his retirement in … Web1 dag geleden · 13.04.2024 - Emma Reeve to support Editas’ evolution in new role as Chair of the Board Elliott Levy, M.D., joins Board as an Independent Director CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE ... Web30 nov. 2024 · Mersana’s lead product candidate, upifitamab rilsodotin (UpRi), is a Dolaflexin ADC targeting NaPi2b and is being studied in UPLIFT, a single-arm registration strategy in patients with platinum-resistant ovarian cancer, as well as in UPGRADE, a Phase 1 umbrella study in combination with other ovarian cancer therapies. tavana nui was mafatu’s grandfather